deferoxamine has been researched along with 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, RP; Camandola, S; Cheng, A; Earley, CJ; Ferré, S; Gleichmann, M; Gulyani, S; Jones, BC; Martin, B; Mattson, MP; Maudsley, S; Mughal, MR | 1 |
1 other study(ies) available for deferoxamine and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine
Article | Year |
---|---|
Diminished iron concentrations increase adenosine A(2A) receptor levels in mouse striatum and cultured human neuroblastoma cells.
Topics: Adenosine; Animals; Cell Line, Tumor; Corpus Striatum; Cyclic AMP; Deferoxamine; Dose-Response Relationship, Drug; Female; Humans; Iron Deficiencies; Iron, Dietary; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neuroblastoma; Phenethylamines; Receptors, Adenosine A2; Receptors, Transferrin; Time Factors; Up-Regulation | 2009 |